drugset / Trial / NCT03228355

Headache Inducing Effect of Cromakalim in Migraine Patients

NCT03228355

Completed 16 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindOther

Summary

To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.

Timeline

Start
2017-05-24
Primary completion
2017-11-30
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levcromakalim Small molecule 0.05 mg

Indications